Click here to create your personal news page. The news that appears on Carrie Cox will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Casio Exilim EX-Z85
  2. 2. Casio Exilim EX-Z250
  3. 3. Casio Exilim EX-Z300
  4. 4. Razer Megalodon
  5. 5. Asus P6T Deluxe
  6. 6. Onkyo TX-SR806
  7. 7. Microsoft Sidewinder X5
  8. go to Shopping

Participate



Carrie Cox


Sort by : relevance - date - popularity
5Vote!
5Vote!

An American Health Care Story

An American Health Care Story A friend wrote this week with this unhappy news: On Sunday night, my former foster child Josh was beaten up with a baseball bat (after being held up at gunpoint and telling the marauders he had no money) on his... California Shoots Down Gov's Health Care Reform Plan A California Senate committee shot down Gov. Arnold Schwarzenegger's health care reform plan by a 7-1

6Vote!

Congress probes Vytorin insider info on CafePharma, first revealed by BrandweekNRX.

Based on a recent article in BrandweekNRX, the House Energy & Commerce Committee is widening its investigation into the handling of the ENHANCE trial and about who knew what at Schering-Plough and Merck. Four weeks ago BrandweekNRX revealed that Schering-Plough's...

11Vote!

New evidence indicates Schering-Plough insiders knew the Vytorin trial was "a bust" on March 13, 2007.

Evidence has just surfaced that Schering-Plough insiders may have known as early as March 13, 2007 that the ENHANCE trial would not show any statistically significant difference between Vytorin and generic Zocor. What Schering employees knew--and when--is important, since there...

8Vote!

Schering-Plough's Magic Show!

A good magicians always shows the audience what he wants them to see and leads their eyes away from the solution to the tricks he performs before them. Schering-Plough has now employed the same trick, by releasing not just the...

9Vote!

Quotes of the day - from Schering-Plough's message board

Re: It's official: Congress goes after Carrie Cox All the breifings took place behind closed doors without records or minutes. Congress will no doubt have a very diificult thing finding anything unless they call the people in question to DC...

11Vote!

Carrie Cox: Should I stay or should I go?

Here's most recent result from Schering-Plough's message board: More than 90% of those voting want to get rid of Carrie Cox. This one will be interesting to watch--will Teflon-Hassan, who has worked with Carrie for years, throw her to the...

5Vote!

Vytorin Prescriptions Fell 9.5% Last Week and Schering-Plough drops another 4%.

Prescriptions for Merck & Co.'s (MRK) and Schering-Plough Corp.'s (SGP) embattled cholesterol drug Vytorin took a hit last week after a study raised questions about its effectiveness, according to a market-research firm. Total U.S. prescriptions written for Vytorin in the...

4Vote!

SEC reviews BrandweekNRX information about unusual Schering-Plough trading activity.

It took a little while, but the Securities & Exchange Commission finally visited BrandweekNRX to review information about Schering-Plough President Carrie Cox's sale of $28 million SGP stock in 2007, a year after the failed Vytorin trial was completed and...

4Vote!

Threat issued against BrandweekNRX reporter on Schering-Plough message board.

Schering-Plough's message board, under the headline "Attention Peter Rost," contained the following threat: "Dr. Rost might need to start sleeping with one eye open if he continues his high level antagonism of huge multinational corporations." Apparently this threat was picked...

4Vote!

The Street questions Schering-Plough motives

Excerpts from The Street: Skip Irvine, director of communications for the joint venture, insists that neither company received any clues about ENHANCE until earlier this month. But skeptics, pointing to stock sales by Schering-Plough insiders, have some doubts. Schering-Plough didn't...

8Vote!

Newsweek on Schering stock options.

It appears that at least one top executive at Schering-Plough, executive vice president Carrie Cox, sold millions of dollars worth of company stock after the trial ended but before the results were made public. How concerned are you about the...

8Vote!

Schering-Plough employees want Carrie Cox fired.

At least if the poll results on Schering-Plough's message board this weekend are to be believed. And reading the comments over the past week the poll seems to be right on the mark. The second choice is to "Make her...

9Vote!

Today Fred Hassan proved that not even Fred Hassan believes in Schering-Plough.

In the last week Schering-Plough has shed 23.4% of its value. If you believe in buying distressed stock, this is the time to swoop in, right? Not so fast. In a feeble attempt to shore up investor confidence, Schering-Plough CEO...

9Vote!

BLOGSCAN - The Sorts of People Who Get to Run Large Health Care Organizations

Back blogging on BrandweekNRX, Dr Peter Rost just posted about the sort of people who now run Schering-Plough, the company that, with Merck Inc, just got a lot of unfavorable publicity after it was involved in delaying the release of results from the ENHANCE trial of ezeimibe (see our last related post here .) According to Rost, " Sean McNicholas is now Schering-Plough's Senior Vice President, responsible...